BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16258645)

  • 1. Topiramate for the treatment of juvenile myoclonic epilepsy.
    Sousa Pda S; Araújo Filho GM; Garzon E; Sakamoto AC; Yacubian EM
    Arq Neuropsiquiatr; 2005 Sep; 63(3B):733-7. PubMed ID: 16258645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy.
    Prasad A; Kuzniecky RI; Knowlton RC; Welty TE; Martin RC; Mendez M; Faught RE
    Arch Neurol; 2003 Aug; 60(8):1100-5. PubMed ID: 12925366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topiramate monotherapy for juvenile myoclonic epilepsy.
    Liu J; Wang LN; Wang YP
    Cochrane Database Syst Rev; 2015 Dec; (12):CD010008. PubMed ID: 26695884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.
    Kothare SV; Valencia I; Khurana DS; Hardison H; Melvin JJ; Legido A
    Epileptic Disord; 2004 Dec; 6(4):267-70. PubMed ID: 15634623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topiramate monotherapy for juvenile myoclonic epilepsy.
    Liu J; Wang LN; Wang YP
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010008. PubMed ID: 28434203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary open-label experience with topiramate in primary generalized seizures.
    Biton V
    Epilepsia; 1997; 38 Suppl 1():S42-4. PubMed ID: 9092959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychiatric profiles of patients with juvenile myoclonic epilepsy treated with valproate or topiramate.
    de Araujo Filho GM; Pascalicchio TF; Lin K; Sousa PS; Yacubian EM
    Epilepsy Behav; 2006 May; 8(3):606-9. PubMed ID: 16504593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topiramate in patients with juvenile myoclonic epilepsy.
    Biton V; Bourgeois BF;
    Arch Neurol; 2005 Nov; 62(11):1705-8. PubMed ID: 16286543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized open-label observational study to compare the efficacy and tolerability between topiramate and valproate in juvenile myoclonic epilepsy.
    Park KM; Kim SH; Nho SK; Shin KJ; Park J; Ha SY; Kim SE
    J Clin Neurosci; 2013 Aug; 20(8):1079-82. PubMed ID: 23673144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonfocal generalized tonic-clonic seizures: response during long-term topiramate treatment. Topiramate YTC/YTCE Study Group.
    Montouris GD; Biton V; Rosenfeld WE
    Epilepsia; 2000; 41(S1):77-81. PubMed ID: 10768306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topiramate: efficacy and tolerability in children according to epilepsy syndromes.
    Mikaeloff Y; de Saint-Martin A; Mancini J; Peudenier S; Pedespan JM; Vallée L; Motte J; Bourgeois M; Arzimanoglou A; Dulac O; Chiron C
    Epilepsy Res; 2003 Mar; 53(3):225-32. PubMed ID: 12694931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topiramate or valproate in patients with juvenile myoclonic epilepsy: a randomized open-label comparison.
    Levisohn PM; Holland KD
    Epilepsy Behav; 2007 Jun; 10(4):547-52. PubMed ID: 17482520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topiramate in the treatment of myoclonic-astatic epilepsy in children: a retrospective hospital audit.
    Jayawant S; Libretto SE
    J Postgrad Med; 2003; 49(3):202-5; discussion 205-6. PubMed ID: 14597780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of topiramate in childhood generalized seizure disorders.
    Wheless JW
    J Child Neurol; 2000; 15 Suppl 1():S7-13. PubMed ID: 11218056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome in adolescent-onset generalized genetic epilepsies.
    Vorderwülbecke BJ; Kowski AB; Kirschbaum A; Merkle H; Senf P; Janz D; Holtkamp M
    Epilepsia; 2017 Jul; 58(7):1244-1250. PubMed ID: 28464258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical effects of topiramate against secondarily generalized tonic--clonic seizures.
    Wang Y; Zhou D; Wang B; Kirchner A; Hopp P; Kerling F; Pauli E; Stefan H
    Epilepsy Res; 2002 Apr; 49(2):121-30. PubMed ID: 12049800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topiramate in the long-term management of refractory epilepsy. Topiramate YOL Study Group.
    Abou-Khalil B
    Epilepsia; 2000; 41(S1):72-6. PubMed ID: 10768305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topiramate in frontal lobe epilepsy.
    Verrotti A; Sofia V; Franzoni E; Coppola G; Manco R; Ciambra GL; Savasta S; Chiarelli F; Iannetti P
    Acta Neurol Scand; 2007 Feb; 115(2):132-5. PubMed ID: 17212619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies.
    Rosenfeld WE; Benbadis S; Edrich P; Tassinari CA; Hirsch E
    Epilepsy Res; 2009 Jul; 85(1):72-80. PubMed ID: 19327967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.